p a ra m eters, su c h a s g a la cto m a n n a n , im m u n o d if fu sio n a n d a ra d io -a lle r g oso rb en t t est , a s w ell a s in f la m m at o r y m a rk e r s s u c h a s C -re a c t iv e p ro t e i n a n d t h e leu k o cy te co u n t , d id n o t sh o w a n y c o n sis ten t te n d en cy g lu c a n in p a tie n ts w it h p u lm o n a ry a sp e rg illo sis a n d f o u n d th a t (1® 3 ) -b -D -g lu c a n in c re a se d in so m e c a se s o f p u lm o n a r y a sp e rg il lo m a , in w h ic h th e f u n g u s w a s c o n sid e re d n o t to h av e inv a d e d th e su rro u n d in g tissu e o r b lo o d stre a m [ 1 ]. I n th e p r e se n t stu d y, to e lu c id a te th e ro le o f (1® 3 ) -b -D -g lu c a n in p u lm o n a r y a sp e r g ill o m a, se r u m co nc e n tr a ti o n s o f ( 1 ® 3 ) -b -D -g lu c a n w e r e m e a su re d rep e a te d ly f o r a s lo n g a s 1 0 m o n th s in e ig h t p a tie n ts.
g lu c a n in p a tie n ts w it h p u lm o n a ry a sp e rg illo sis a n d f o u n d th a t (1® 3 ) -b -D -g lu c a n in c re a se d in so m e c a se s o f p u lm o n a r y a sp e rg il lo m a , in w h ic h th e f u n g u s w a s c o n sid e re d n o t to h av e inv a d e d th e su rro u n d in g tissu e o r b lo o d stre a m [ 1 ] . I n th e p r e se n t stu d y, to e lu c id a te th e ro le o f (1® 3 ) -b -D -g lu c a n in p u lm o n a r y a sp e r g ill o m a, se r u m co nc e n tr a ti o n s o f ( 1 ® 3 ) -b -D -g lu c a n w e r e m e a su re d rep e a te d ly f o r a s lo n g a s 1 0 m o n th s in e ig h t p a tie n ts.
M aterials an d m eth o d s

Sub jects
E ig h t p a tie n ts w it h p u lm o n a ry a s p e r g ill o m a w e r e e n ro lle d in th e stu d y ( Ta b le 1 ) . O f th e e ig h t p a tie n ts, th e d ise a se w a s in a c tiv e in six . I n p atie n t 7 , h e m osp u tu m w a s fr e q u e n tly o b se r v ed th ro u g h o u t th e fo llow -u p p e rio d , a n d in p a tie n t 8 , th e fu n g u s b a ll ste a dily in c r e a se d in siz e. T h e d isea se w a s ju d g e d to b e a c tiv e in th e se tw o p atie n ts. I tr a c o n a z o le (I T C Z ) at 1 0 0 ±2 0 0 m g /d a y, w a s a d m in iste r e d th ro u g h o u t th e fo llow -u p p e rio d to a ll b u t p a ti e n t 7 .
Clin ical evalua tio n
T h e p a ti e n t' s p h y sic a l c o n d itio n , a c h e st X -r ay a n d b lo o d te sts (le u k o cy te c o u n t, C -re a ctiv e p ro te in ) w e re e x am in e d o n c e a m o n th in e a c h p atie n t to e v a lu a t e th e a c tiv it y o f th e d ise a se . T h e A sp e rg illu s -sp e c ific c e ll -su r fa c e c o m p o n e n t g ala c to m a n n a n w a s a ssa y e d w ith P a sto re x A sp e rg illu s ( S a n o fi D ia g n o stic s P a ste u r, G e n k , B e lg iu m ). T h e se n sit iv ity o f th e te st w a s 1 5 n g /m l o f g a la cto m a nn a n [ 6 ] .
R esu lts an d d isc u ssio n
O n th e b asis o f th e c o n c e n tra tio n o f ( 1 ® 3 ) -b -D -g luc a n a n d th e clin ic a l a c tiv ity o f p u lm o n a ry a sp e rg il lom a , th e p atie n ts w e r e cla ssifie d in to th re e g r o u p s :
lu c a n w ith in a c tiv e d ise a se ; g r o u p 2 , in c re a se d (1 ® 3 ) -b -D -g lu c a n w ith ina c tiv e d isea se ; a n d gr o u p 3 , in c re a sed (1 ® 3 ) -b -D -g luc a n w it h a ctiv e d ise a se . G r o u p 1 c o n siste d o f p a tie n ts 1 ±4 (T ab le 2 ) . In th is g r o u p , th e va lu e s o f g a la c to m a n n a n , im m u n o d iff usio n , r a d io -a ll e rg o so r b e n t te st a n d C -r e a c ti v e p ro te in w e re va riab le in e a c h p a tie n t, a n d th e r e w e re n o s ign ifi c a n t c o rr e la ti o n s a m o n g th e se v a lu e s. P a tie n ts 5 a n d 6 w e re c la ssif ie d in g ro u p 2 (Tab l e 3 ). In th is g r o u p , ( 1® 3 ) -b -D -g lu c a n ex c e e d e d 2 0 p g / m l. H ow eve r, th e r e w e re n o o b v io u s sig n s o f a c tiv e d ise a se . O th e r p a ra m e te rs , su c h a s g a la c to m a n n a n , im m u n o d iff u sio n , th e r a d io -a lle rg o so r b e n t te st a n d . P ati e n t 7 h a d c o m p la in e d o f fr eq u e n t h e m o sp u tu m sin c e 1 9 7 9 , w h e n h e w a s d iag n o se d a s su ff e rin g fro m p u lm o n a ry a sp e r g il lo m a . I n th is c a se , va lu e s o f (1 ® 3 ) -b -D -g lu c a n a n d r a d io -a ll e rg o so rb e n t te st w e re e lev ate d. G a la c to m a n n a n w a s se ld o m d e te c te d , h ow e v e r. In p a tie n t 8 , th e f u n g u s b a ll sh ow e d stea d y g ro w th u n ti l 1 9 9 5 , w h e n th e p a ti e n t w a s e n ro ll e d in th e stu d y. In th is c a se , to e lu c id a te th e d a y -to -d a y va ri atio n , th e c o n c e n tra tio n s o f ( 1® 3 ) -b -D -g lu c a n w e r e m e a su re d d aily fo r 2 w e e k s. T h e siz e o f th e fu n g u s b a ll r em a in e d u n c h a n ge d a n d ( 1 ® 3 ) -b -D -g lu c a n v a lu e s w e re n o rm a liz e d d u r in g th e p e rio d . I n c o n t r a s t t o t h e p r ev a l e n t n o t i o n , i n c r e a s e d 
